Introduction: Volume recommendations of 80–200 mL have been proposed for peritoneal fluid cytology. While cutoffs are impractical when volume is limited by the amount present and disease factors, collections, however, can be repeated. This study addresses adequacy and number needed to diagnose by comparing diagnostic agreement to volumes in single specimens, total volumes collected daily, and within admissions. The diagnostic yield of repeating collection within a single day, admission, and throughout admissions of a patient’s lifetime was also investigated. Methods: Peritoneal fluid cytology specimens over a 27-year period were retrieved and matched by collection date, admission number, and patient number. Case notes were reviewed to establish all cases of malignant ascites. Results: In total, 19,392 specimens from 14,327 admissions and 11,089 patients were retrieved, with 1,531 patients confirmed with malignant ascites. Agreements between cytologic diagnoses within the same day and admission were high (κ > 0.8). Fluid volume increased with grade of cytologic diagnosis (p < 0.001), and greater volume was associated with higher discordance (p < 0.05). Specimens of 60–100 mL showed the best diagnostic concordance. To achieve a 99.5% diagnostic rate, three sequential aliquots, collections from two different days in an admission, or three admissions within a lifetime are required. The diagnostic yield of one aliquot within batches from the same day was only 88.9%. Gastrointestinal (p = 0.040), gynecologic (p = 0.005), and lung (p < 0.001) malignancies required the least repeats for diagnosis. Conclusions: Omission of any fluid from laboratory submission is strongly discouraged. As a simple rule, three repeats are necessary for excluding malignant ascites.

1.
Rooper
LM
,
Ali
SZ
,
Olson
MT
.
A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases
.
J Am Soc Cytopathol
.
2016
;
5
(
5
):
301
5
.
2.
Zhang
F
,
Feng
Z
,
Zhang
Y
,
Liu
Z
,
Sun
X
,
Jin
S
.
Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites
.
Saudi J Gastroenterol
.
2019
;
25
(
5
):
327
32
.
3.
Coconubo
DM
,
Baskota
SU
,
Li
R
,
Srivastava
P
,
Cuda
J
,
Khader
S
.
Reassessing the optimal volume for malignancy detection in serous fluid cytology
.
Cancer Cytopathol
.
2022
;
130
(
7
):
551
7
.
4.
Matsusaki
K
,
Aridome
K
,
Emoto
S
,
Kajiyama
H
,
Takagaki
N
,
Takahashi
T
.
Clinical practice guideline for the treatment of malignant ascites: section summary in clinical practice guideline for peritoneal dissemination (2021)
.
Int J Clin Oncol
.
2022
;
27
(
1
):
1
6
.
5.
Weinstein
PJ
,
Noyer
CM
.
Rapid onset of massive ascites as the initial presentation of systemic lupus erythematosus
.
Am J Gastroenterol
.
2000
;
95
(
1
):
302
3
.
6.
Li
ZY
,
Tang
L
,
Li
ZM
,
Li
YL
,
Fu
J
,
Zhang
Y
.
Four-point computed tomography scores for evaluation of occult peritoneal metastasis in patients with gastric cancer: a region-to-region comparison with staging laparoscopy
.
Ann Surg Oncol
.
2020
;
27
(
4
):
1103
9
.
7.
Kagawa
S
,
Shigeyasu
K
,
Ishida
M
,
Watanabe
M
,
Tazawa
H
,
Nagasaka
T
.
Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients
.
World J Gastroenterol
.
2014
;
20
(
47
):
17796
803
.
8.
Saif
MW
,
Siddiqui
IA
,
Sohail
MA
.
Management of ascites due to gastrointestinal malignancy
.
Ann Saudi Med
.
2009
;
29
(
5
):
369
77
.
9.
Pinto
D
,
Cruz
E
,
Branco
D
,
Linares
C
,
Carvalho
C
,
Silva
A
.
Cytohistological correlation in pleural effusions based on the international system for reporting serous fluid cytopathology
.
Diagnostics Basel
.
2021
;
11
(
6
):
1126
.
10.
Poon
IK
,
Chan
RCK
,
Choi
JSH
,
Ng
JKM
,
Tang
KT
,
Wong
YYH
.
Reply to: a comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation: a methodological issue
.
Cancer Med
.
2022
11.
Saieg
M
,
Sundling
K
,
Kurtycz
D
.
Non-diagnostic (ND) Adequacy
. In:
Chandra
A
,
Crothers
B
,
Kurtycz
D
,
Schmitt
F
, editors. The international system for serous fluid cytopathology.
Cham
Springer International Publishing
2020
. p.
9
15
.
12.
Crothers
B
,
Baloch
Z
,
Chandra
A
,
Farahani
S
,
Kurtycz
D
,
Schmitt
F
.
The international system for reporting serous fluid cytopathology: introduction and overview of diagnostic terminology and reporting
. In:
Chandra
A
,
Crothers
B
,
Kurtycz
D
,
Schmitt
F
, editors. The international system for serous fluid cytopathology.
Cham
Springer International Publishing
2020
. p.
1
7
.
13.
Quan
Q
,
Zhou
S
,
Liu
Y
,
Yin
W
,
Liao
Q
,
Ren
S
.
Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer
.
J Obstet Gynaecol Res
.
2021
;
47
(
4
):
1527
35
.
14.
Lindsay
AJ
,
Burton
J
,
Ray
CE
Jr
.
Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist
.
Semin Intervent Radiol
.
2014
;
31
(
3
):
276
8
.
15.
Shidham
VB
.
Collection and processing of effusion fluids for cytopathologic evaluation
.
Cytojournal
.
2022
;
19
:
5
.
16.
Treml
B
,
Rajsic
S
,
Diwo
F
,
Hell
T
,
Hochhold
C
.
Small drainage volumes of pleural effusions are associated with complications in critically Ill patients: a retrospective analysis
.
J Clin Med
.
2021
;
10
(
11
):
2453
.
17.
Lengyel
E
.
Ovarian cancer development and metastasis
.
Am J Pathol
.
2010
;
177
(
3
):
1053
64
.
18.
Karoo
RO
,
Lloyd
TD
,
Garcea
G
,
Redway
HD
,
Robertson
GS
.
How valuable is ascitic cytology in the detection and management of malignancy
.
Postgrad Med J
.
2003
;
79
(
931
):
292
4
.
19.
Satoh
H
,
Ishikawa
H
,
Yamashita
YT
,
Kurishima
K
,
Ohtsuka
M
,
Sekizawa
K
.
Peritoneal carcinomatosis in lung cancer patients
.
Oncol Rep
.
2001
;
8
(
6
):
1305
7
.
20.
Gerber
LD
,
Sgro
G
,
Cyr
JE
,
Conlin
S
.
An academic hospitalist-run outpatient paracentesis clinic
.
Fed Pract
.
2022
;
39
(
3
):
114
9
.
21.
Ota
KS
,
Schultz
N
,
Segaline
NA
.
Palliative paracentesis in the home setting: a case series
.
Am J Hosp Palliat Care
.
2021
;
38
(
8
):
1042
5
.
You do not currently have access to this content.